(INCY:Consolidated Issue Listed on NASDAQ Global Select )
Richard S. Levy M.D.
Chief Drug Development Officer and Executive Vice President, Incyte Corporation
|Age||Total Calculated Compensation||This person is connected to 5 board members in 1 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Richard S. Levy, also known as Rich, M.D. has been the Chief Drug Development Officer & Medical Officer and Executive Vice President of Incyte Corporation since January 2009. Dr. Levy served as the Senior Vice President of Drug Development of Incyte Corporation since August 26, 2003. He has over 12 years of experience in the pharmaceutical and biotechnology sectors through his prior positions at Celgene, DuPont Pharmaceuticals and Novartis. Most recently, he served ...
1801 Augustine Cut-OffPhone: 302-498-6700
Wilmington, Delaware 19803
Board Members Memberships*
The University of Pennsylvania
|Richard F. Pops||Chairman of the Board and Chief Executive Officer|
|Harvey J. Berger M.D.||Principal Founder, Chairman, Chief Executive Officer and President|
Ariad Pharmaceuticals Inc.
|Jean-Jacques Bienaime MBA||Chairman and Chief Executive Officer|
BioMarin Pharmaceutical Inc.
|Jeffrey M. Leiden M.D., Ph.D.||Chairman, Chief Executive Officer and President|
Vertex Pharmaceuticals Incorporated
|Bruce C. Cozadd||Co-Founder, Executive Chairman and Chief Executive Officer|
Jazz Pharmaceuticals Public Limited Company
|$830.0K||Compensation as of Fiscal Year 2014.|